Skip to main content
. Author manuscript; available in PMC: 2012 Jul 10.
Published in final edited form as: Mol Cancer Ther. 2009 Jun 9;8(6):1589–1595. doi: 10.1158/1535-7163.MCT-09-0038

Figure 1.

Figure 1

Histone acetylation status determined after exposure to and removal of vorinostat. MDA-MB-231-BR cells were either exposed to vorinostat (1 µmol/L) for 16 h and collected (time 0 h) for immunoblot analysis of acetylated histone H3 or exposed to vorinostat (1 µmol/L) for 16 h; medium was removed; and cells were rinsed with PBS, fed fresh drug-free medium, and collected 6 h later for immunoblot analysis. C, cultures exposed to the vehicle only (DMSO).